Report an error

Spotted something inaccurate in “Novel Biweekly GLP-1 Agonist Bofanglutide Outperforms Semaglutide in HbA1c Reduction”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.